Monoclonal antibodies trigger the immune system to attack and kill cancer cells. Although cancer cells are abnormal, they develop from normal cells so they can be difficult for the immune system to spot. Some monoclonal antibodies simply attach themselves to cancer cells, making them easier for the cells of the immune system to find them. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals. OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. It follows an Open Access publication model that enables the dissemination of research articles to the global community free of cost. Journal of Glycobiology is one of the top Peer-reviewed open access journals that emphasises Glycobiology Research and development. It publishes original research articles, novel, and scientifically sound findings dealing with Cancer Glycobiology, Glycopeptides, drug discovery and Glycomics, Fucanomes and Galactanomes, Structural Glycobiology, Membrane glycoproteins, Protein De glycosylation and carbohydrate diet. Journal of Glycobiology is among the top peer review journals which publishes the articles related to Monoclonal antibodies. Journal of Glycobiology provide a forum for Scientists from all over the world to exchange ideas, to propagate the advancement of science.
Last date updated on July, 2021